Welcome to the Connect Ovar Coffee Podcast, the show that brings you hope and inspires you to embrace the spirit of OVARCOMING! Each month, we deliver the latest & greatest information on progress and advances in ovarian cancer screening, diagnosis, treatment, and survivorship. Listen. Subscribe. SHARE! THIS is how #WeOvarcome! Let’s Connect Ovar Coffee!

Connect Ovar Coffee
Claim This Podcastby OVARCOME
Podcast Authority
Beta
Podcast Overview
Welcome to the Connect Ovar Coffee Podcast, the show that brings you hope and inspires you to embrace the spirit of OVARCOMING! Each month, we deliver the latest & greatest information on progress and advances in ovarian cancer screening, diagnosis, treatment, and survivorship. Listen. Subscribe. SHARE! THIS is how #WeOvarcome! Let’s Connect Ovar Coffee!
Language
🇺🇲
Publishing Since
1/13/2022
Unlock The Full Podcast Authority Score Report
See how your podcast performs across key metrics
Podcast Authority
Beta
Recommendations available
Unlock the full report to see detailed tips
Recommendations available
Unlock the full report to see detailed tips
Unlock comprehensive insights including:
- • YouTube presence analysis
- • Social media reach metrics
- • RSS compliance scoring
- • Podcast 2.0 features
- • Technical standards
Detailed Analytics
- Complete breakdown of all 19 authority metrics
- Personalized recommendations for each metric
- Industry benchmarks and comparisons
- Technical RSS feed analysis and compliance scoring
Growth Strategies
- Step-by-step action plans for improvement
- Quick wins to boost your score immediately
- Pro tips from successful podcasters
See how your show performs across every key metric
High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.
Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.
Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.
1 verified contact email on file for Connect Ovar Coffee
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes

June 9, 2026
Biomarkers & Clinical Trial Advances in Ovarian Cancer
<p>We sit down on this episode to Connect Ovar Coffee with with Global Expert Dr. Angeles Secord, the Lead Investigator of the RINA-S trial, the former President of the <a href="https://www.facebook.com/SGO.org?__cft__[0]=AZYzs0AbUZFB7ZGaO3eX08n-IN5x7xPtQqLgWLao3KJ3kuO-wC5-PBJnWhLygbX9QngQOay57ExFNEnpSgeIectRTIe_GXKyc3r7TBY96kcCLSZl9eyZG-bnq54MOOIci8z6Jo9uH-0VVFfocDmvI_rlhYafzpijQq6I9w3Ct4qD5R23U3FJsVGjqrNW7MTPleo&__tn__=-]K-R"><strong>Society of Gynecologic Oncology</strong></a> and Professor, Gynecologic Oncology, at <a href="https://www.facebook.com/DukeUniv?__cft__[0]=AZYzs0AbUZFB7ZGaO3eX08n-IN5x7xPtQqLgWLao3KJ3kuO-wC5-PBJnWhLygbX9QngQOay57ExFNEnpSgeIectRTIe_GXKyc3r7TBY96kcCLSZl9eyZG-bnq54MOOIci8z6Jo9uH-0VVFfocDmvI_rlhYafzpijQq6I9w3Ct4qD5R23U3FJsVGjqrNW7MTPleo&__tn__=-]K-R"><strong>Duke University</strong></a> Cancer Center, to talk about: </p><p>1. Biomarkers - established, emerging, and in the pipeline </p><p>2. Clinical Trials, focusing on RINA - S</p><p>3. ADCs </p><p>4. Combination Therapies </p><p>5. + Much More</p>

April 13, 2026
Dr. Alexander Olawaiye: Inside Platinum Resistant Ovarian Cancer - Actions & Insights
<p><strong>Connect Ovar Coffee: Dr. Alexander Olawaiye</strong></p><p>This episode features Dr. Alexander Olawaiye, discussing major advances in ovarian cancer treatment, including the ROSELLA clinical trial.<br> <br> <strong>Key Highlights:</strong><br> 1. <strong>Ovarian Cancer Challenges:</strong><br> - No reliable early screening methods<br> - Majority diagnosed at advanced stages (Stage III/IV)<br> - Early detection remains a critical unmet need<br> <br> 2. <strong>ROSELLA Trial Breakthrough:</strong><br> - Focus on platinum-resistant ovarian cancer<br> - Combines relacorilant (a glucocorticoid receptor antagonist) with nab-paclitaxel<br> - Demonstrated improved progression-free survival and overall survival<br> - No biomarker requirement, making it accessible to more patients<br> <br> 3. <strong>Mechanism of Action:</strong><br> - Relacorilant blocks cortisol signaling that promotes chemotherapy resistance<br> - Enhances effectiveness of chemotherapy<br> <br> 4. <strong>Safety & Tolerability:</strong><br> - No new major toxicities identified<br> - Side effects consistent with standard chemotherapy<br> <br> 5. <strong>Clinical Trial Importance:</strong><br> - Patients in trials often experience better outcomes<br> - Participation helps advance future treatments<br> <br> 6. <strong>Health Equity & Access:</strong><br> - Disparities exist in access to care and clinical trials<br> - Need to improve awareness, access, and inclusion<br> <br> 7. <strong>Future Outlook:</strong><br> - Rapid growth in new treatments over past decade<br> - Emerging therapies include antibody-drug conjugates<br> - Continued innovation offers hope for patients<br> <strong><br> Closing Message:</strong><br>Stay informed, consider clinical trials, and remain hopeful as new treatments continue to emerge.<br> <br><br></p>

February 3, 2026
Innovative Advances in Ovarian Cancer Care
<p>1. Future of Gynecologic Oncology and Clinical Trials <br>2. ADCs (antibody drug conjugates) - what we should know <br>3. Immunity and Immunotherapy <br>4. CAR-T Cell Therapy <br>5. Vaccines <br>+ MORE! <br>We discuss on this episode of Connect Ovar Coffee with the Chair of Gynecologic Oncology at Moffitt Cancer Center, Dr. Robert Wenham. <br>Learn, Share and Be Empowered 💪.<br>Let's #ConnectOvarCoffee</p>
52 total episodes available
Deep-dive analytics for Connect Ovar Coffee
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Connect Ovar Coffee?
- How often does this podcast release new episodes?
This podcast updates bi-weekly.
- Where can I listen to this podcast?
This podcast is available on 8 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
No, this podcast does not typically feature guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.